Scorpion Envenomation Clinical Presentation
- Author: David Cheng, MD; Chief Editor: Rick Kulkarni, MD more...
History
For patients presenting with scorpion stings, ascertaining the following is essential:
- Time of envenomation
- Nature of the incident
- Description of the scorpion: Specimen identification by an entomologist may be helpful (if the scorpion can be captured safely).
- Local and systemic symptoms: Pain and paresthesias often are present. Nausea and vomiting are common.
The toxicity, variation, and duration of the symptoms depends on the following factors:
- Scorpion species
- Scorpion age, size, and nutritional status
- Healthiness of the scorpion's stinging apparatus (telson)
- Number of stings and quantity of venom injected
- Depth of the sting penetration
- Composition of the venom
- Site of envenomation: Closer proximity of the sting to the head and torso results in quicker venom absorption into the central circulation and a quicker onset of symptoms.
- Age of the victim
- Health of the victim
- Weight of the victim relative to amount of venom
- Presence of comorbidities
- Treatment effectiveness
Generally, intrathecal and intravenous routes have immediate effects, while subcutaneous and intramuscular routes take effect several minutes to hours later.
Nonlethal scorpion species tend to produce local reactions similar to a hymenopteran sting, while lethal scorpion species tend to produce systemic symptoms. The duration to progress to systemic symptoms ranges from 5 minutes to 4 hours after the sting. The symptoms generally persist for 10-48 hours.
Physical
Clinical manifestations range from minor local tenderness to multisystem failure followed by death.[7]
- Local tissue effects vary among species.
- Minimal local tissue effects are present with Centruroides envenomation.
- Significant local tissue reaction rules out C exilicauda envenomation.
- Tapping over the injury site (ie, tap test) may cause severe pain after a sting by C exilicauda.
- Tachycardia and other dysrhythmias are caused by autonomic effects primarily, although direct myocardial toxicity with arrhythmogenic effects has been described.
- Hypertension or hypotension may be present.
- The patient may have hyperthermia.
- Respiratory arrest and loss of protective airway reflexes are common causes of mortality.
- Pulmonary edema has been described and may be secondary to cardiogenic causes and to increased capillary permeability.
- Autonomic effects include the following:
- Sympathetic overdrive symptoms predominate, causing tachycardia, hypertension, hyperthermia, and pulmonary edema.
- Parasympathetic symptoms include hypotension, bradycardia, salivation, lacrimation, urination, defecation, and gastric emptying.
- Cranial nerve effects include the following:
- Classic roving or rotary eye movements, blurred vision, tongue fasciculations, and loss of pharyngeal muscle control may be observed.
- Difficulty swallowing combined with excessive salivary secretions may lead to respiratory difficulty.
- Somatic effects include the following:
- Restlessness and involuntary muscle jerking that can be mistaken for seizures have been described.
- Presence of true seizures in Centruroides envenomation is controversial and has not been proven to occur. Seizures are described in association with other scorpion envenomations.
Cerebral infarction, cerebral thrombosis, and acute hypertensive encephalopathy have been described with a variety of Buthidae scorpion envenomations.
The signs of the envenomation are determined by the scorpion species, venom composition, and the victim's physiological reaction to the venom. The signs occur within a few minutes after the sting and usually progress to a maximum severity within 5 hours. The signs last for 24-72 hours and do not have an apparent sequence. Thus, predicting the evolution of signs over time is difficult. Furthermore, a false recovery followed by a total relapse is common.
A person who has been stung by a scorpion usually has 4 signs, with the most common being mydriasis, nystagmus, hypersalivation, dysphagia, and restlessness. The mode of death is usually via respiratory failure secondary to anaphylaxis, bronchoconstriction, bronchorrhea, pharyngeal secretions, and/or diaphragmatic paralysis, even though venom-induced multiorgan failure plays a large role.
Children present with the same symptoms and signs as adults, except their symptoms are more severe and protracted. Furthermore, they may display a restlessness that is out of proportion when compared to any other disease. A child's symptoms have been described as inconsolable crying; uncontrollable jerking of the extremities; and chaotic thrashing, flailing, and writhing combined with contorted facial grimaces. The symptoms mimic a centrally mediated seizure, but the patient is awake and alert the entire time.
The grading of these scorpion envenomations depends on whether or not neurological signs predominate and is as follows:
- Nonneurological predominance
- Mild - Local signs
- Moderate - Ascending local signs or mild systemic signs
- Severe - Life-threatening systemic signs
- Neurologic predominance
- Grade I - Local pain or paresthesia at the sting site (83%)
- Grade II - Pain or paresthesia that has traveled from the sting site (9.1%)
- Grade III - Either cranial nerve or somatic neuromuscular dysfunction (4.7%)
- Grade IV - Both cranial nerve and somatic neuromuscular dysfunction (3%)
Local signs
- Neurotoxic local effects
- Local evidence of a sting may be minimal or absent in as many as 50% of cases of neurotoxic scorpion stings. In fact, tissue necrosis is rarely found.
- A sharp burning pain sensation at the sting site, followed by pruritus, erythema, local tissue swelling, and ascending hyperesthesia, may be reported. This paresthesia feels like an electric current, persists for several weeks, and is the last symptom to resolve before the victim recovers.
- The tap test is administered by tapping at the sting site. A positive result is when the paresthesia worsens with the tapping because the site is hypersensitive to touch and temperature. In fact, wearing clothing over the area and sudden changes in temperature exacerbate the symptoms. Tapping over the injury site (ie, tap test) may cause severe pain after a sting by C exilicauda.
- Cytotoxic local effects
- A macule or papule appears initially at the sting site, occurring within the first hour of the sting.
- The diameter of the lesion is dependent on the quantity of venom injected.
- The lesion progresses to a purpuric plague that will necrose and ulcerate.
- Lymphangitis results from the transfer of the venom through the lymphatic vessels.
- Nonlethal local effects
- Pain, erythema, induration, and wheal may be present.
- These are secondary to venom activation of kinins and slow-releasing substances.
- Local tissue effects vary among species. Minimal local tissue effects are present with Centruroides envenomation. Significant local tissue reaction rules out C exilicauda envenomation.
Neurologic signs
Most of the symptoms are due to either the release of catecholamines from the adrenal glands (sympathetic nerves) or the release of acetylcholine from postganglionic parasympathetic neurons. One study by Freire-Maia et al (1974) found that the adrenergic signs occur at a low venom dose, while cholinergic signs occur at high venom dose concentrations (ie, >40 mcg/100 g in Tityus serrulatus scorpion venom).[8] Furthermore, the adrenergic phase tended to be more dependent on the venom dose than the cholinergic phase. However, dual manifestations of the adrenergic and cholinergic signs are possible because of varying organ system sensitivities to these neurotransmitters.
- Central nervous system signs
- Thalamus-induced systemic paresthesia occurs in all 4 limbs.
- Patients experience venom-induced cerebral thrombosis strokes.
- The level of consciousness is altered, especially with restlessness, confusion, or delirium.
- Patients have abnormal behavior.
- Ataxia is also a sign.
- Autonomic nervous system signs - Predominately sympathetic signs, parasympathetic signs, or a combination of signs
- Sympathetic signs
- Hyperthermia
- Tachypnea
- Tachycardia
- Hypertension
- Arrhythmia
- Hyperkinetic pulmonary edema
- Hyperglycemia
- Diaphoresis
- Piloerection
- Restlessness and apprehension
- Hyperexcitability and convulsions
- Sympathetic signs
- Parasympathetic signs
- Bronchoconstriction
- Bradycardia
- Hypotension
- Salivation, lacrimation, urination, diarrhea, and gastric emesis (SLUDGE)
- Rhinorrhea and bronchorrhea
- Goose pimple skin
- Loss of bowel and bladder control
- Priapism
- Dysphagia
- Miosis
- Generalized weakness
- Somatic signs
- Rigid spastic muscle of the limbs and torso
- Involuntary muscle spasm, twitching, clonus, and contractures
- Alternating opisthotonos and opisthotonus from inactivation of sodium channels, leading to increased sodium and calcium uptake
- Increased tendon reflexes, especially prolongation of the relaxation phase
- Piloerection accompanied by goose pimples
- Cranial nerve signs
- Classic rotary eye movement may result in ptosis, nystagmus, and blurred vision.
- Mydriasis is a sign.
- Patients may have tongue fasciculations.
- Dysphagia, dysarthria, and stridor occur secondary to pharyngeal reflex loss or muscle spasm.
- Patients may present with excessive salivation and drooling.
- Peripheral nervous system signs - Intense local burning pain with minimal swelling at sting site, followed by ascending numbness and tingling, then paralysis and convulsions
Nonneurologic systemic signs
- Cardiovascular signs - Usually follow a pattern of a hyperdynamic phase followed by a hypodynamic phase
- Hypertension is described as follows:
- Secondary to catecholamine and renin stimulation
- Observed as early as within 4 minutes after the sting
- Lasts a few hours
- High enough to produce hypertensive encephalopathy
- Hypotension - Less common and occurs secondary to excess acetylcholine or catecholamine depletion
- Hypertension is described as follows:
- Tachycardia is greater than 130 beats per minute, although bradycardia can be observed.
- Transient apical pansystolic murmur is consistent with papillary muscle damage.
- Cardiovascular collapse occurs secondary to toxin induced myocarditis biventricular dysfunction and profuse loss of fluids from sweating, vomiting, diarrhea, and hypersalivation.
- Observed in 7-38% of cardiovascular cases
- Mild envenomation - Vascular effect with vasoconstriction hypertension
- Moderate envenomation - Left ventricular failure hypotension with and without an elevated pulmonary artery wedge pressure, depending on fluid status of the patient
- Severe envenomation - Biventricular cardiogenic shock
- Cardiac dysfunctions attributed to catecholamine-induced myocarditis and increases in myocardial metabolism oxygen demand (leading to myocardial ischemia–induced myocardial hypoperfusion) as well as to the direct effects of the toxin (leading to myocarditis and myocardial conduction interference)[9]
- Respiratory signs
- Tachypnea may be present.
- Pulmonary edema with hemoptysis and a normal-sized heart is observed in 7-32% of respiratory cases. This is secondary to a direct toxin-induced increased pulmonary vessel permeability effect and is also secondary to catecholamine-induced effects of hypoxia and intracellular calcium accumulation, which leads to a decrease in left ventricular compliance with resultant ventricular dilation and diastolic dysfunction.
- Respiratory failure may occur secondary to diaphragm paralysis, alveolar hypoventilation, and bronchorrhea.
- Allergic signs
- Patients may have urticaria.
- Angioedema is reported.
- Patients may present with bronchospasm.
- Anaphylaxis is possible.
- Gastrointestinal signs
- Patients may present with excessive salivation.
- Dysphagia is possible.
- Nausea and vomiting are reported.
- Gastric hyperdistention occurs secondary to vagal stimulation.
- Increased gastric acid output may lead to gastric ulcers.
- Acute pancreatitis may lead to hyperglycemia.
- Liver glycogenolysis may occur from catecholamine stimulation.
- Toxic hepatitis
- Genitourinary signs
- Patients have decreased renal plasma flow.
- Toxin-induced acute tubular necrosis renal failure may occur.
- Rhabdomyolysis renal failure may result from venom-induced excessive motor activity.
- Priapism may occur secondary to cholinergic stimulation. One small study by Bawaskar (1982) found a positive prognostic correlation to the development of cardiac manifestations following scorpion stings.[10]
- Hematological signs
- Platelet aggregation may occur because of catecholamine stimulation.
- Disseminated intravascular coagulation with massive hemorrhage may result from venom-induced defibrination.
- Metabolic signs
- Hyperglycemia may occur from catecholamine-induced hepatic glycogenolysis, pancreatitis, and insulin inhibition.
- Increased lactic acidosis may occur from hypoxia and venom-induced increased lactase dehydrogenase activity.
- Patients may have an electrolyte imbalance and dehydration from hypersalivation, vomiting, diaphoresis, and diarrhea.
- Pregnancy signs - Toxin-induced uterine contraction
- Symptoms predictive of hospital admission
- Priapism (odds ratio 150.59)
- Vomiting (odds ratio 15.82)
- Systolic blood pressure (SBP) greater than 160 (odds ratio 13.38)
- Temperature greater than 38ºC (odds ratio 3.66)
- Heart rate greater than 100 beats per minute (odds ratio 3.35)
Symptomology of specific scorpion species
- Mesobuthus, Tityus, and Leiurus - Tend to cause severe cardiovascular symptoms
- Centruroides - Tend to cause neurological symptoms
- Hemiscorpius - Tend to cause tissue necrosis
Causes
The causes of scorpion envenomation are primarily accidental. Scorpions are shy creatures and only sting if threatened, cornered, or disturbed (eg, being sat or stepped upon). Curious individuals are at risk because of increased interaction with the scorpion.
- The median lethal dose 50 (LD50) of various scorpion venoms in mg/kg of a subcutaneous injection into mice and the territorial distribution are listed below. Unfortunately, humans are much more sensitive than mice.
- Leiurus quinquestriatus (Middle East) - 0.25 mg/kg
- Androctonus crassicauda (Saudi Arabia) - 0.08-0.5 mg/kg
- Centruroides noxius (Mexico) - 0.26 mg/kg
- Androctonus mauritanicus (North Africa) - 0.32 mg/kg
- Centruroides santa maria (Central America) - 0.39 mg/kg
- Tityus serrulatus (Brazil) - 0.43 mg/kg
- Buthus occitanus (North Africa) - 0.9 mg/kg
- Centruroides sculpturatus (Southwest United States) - 1.12 mg/kg
- Mesobuthus eupeus (Iran) - 1.45 mg/kg
- Generally, most lethal scorpions have an LD50 below 1.5 mg/kg.
- The average yield per scorpion via electrical excitation of the venom gland for a few species is listed below.
- Tityus species - 0.39-0.62 mg
- L quinquestriatus - 0.62 mg
- Buthus species - 0.38-1.5 mg
- Milking the venom gland produces approximately a 4-fold increase in yield amount compared to electrical excitation.
Chippaux JP, Goyffon M. Epidemiology of scorpionism: a global apprasial. Acta Trop. 2010/08;107:71-9.
Jahan S, Mohammed Al Saigul A, Abdul Rahim Hamed S. Scorpion stings in Qassim, Saudi Arabia--a 5-year surveillance report. Toxicon. Aug 2007;50(2):302-5. [Medline].
Shahbazzadeh D, Amirkhani A, Djadid ND, Bigdeli S, Akbari A, Ahari H. Epidemiological and clinical survey of scorpionism in Khuzestan province, Iran. Toxicon. Mar 15 2009;53(4):454-9. [Medline].
Langley RL, Morrow WE. Deaths resulting from animal attacks in the United States. Wilderness Environ Med. Feb 1997;8(1):8-16. [Medline].
Boyer L, Heubner K, McNally J, Buchanan P. Death from Centruroides scorpion sting allergy [abstract]. J Toxicol Clin Toxicol. 2001;39:561-562.
Bosnak M, Ece A, Yolbas I, Bosnak V, Kaplan M, Gurkan F. Scorpion sting envenomation in children in southeast Turkey. Wilderness Environ Med. Summer 2009;20(2):118-24. [Medline].
Parma JA, Palladino CM. [Scorpion envenomation in Argentina]. Arch Argent Pediatr. Apr 2010;108(2):161-7. [Medline].
Freire-Maia L, Pinto GI, Franco I. Mechanism of the cardiovascular effects produced by purified scorpion toxin in the rat. J Pharmacol Exp Ther. Jan 1974;188(1):207-13. [Medline].
Pinto MC, Borboleta LR, Melo MB, Labarrére CR, Melo MM. Tityus fasciolatus envenomation induced cardio-respiratory alterations in rats. Toxicon. Jun 1 2010;55(6):1132-7. [Medline].
Bawaskar HS. Diagnostic cardiac premonitory signs and symptoms of red scorpion sting. Lancet. Mar 6 1982;1(8271):552-4. [Medline].
Figueiredo AB, Cupo P, Pintya AO, Caligaris F, Marin-Neto JA, Hering SE. [Assessment of myocardial perfusion and function in victims of scorpion envenomation using gated-SPECT]. Arq Bras Cardiol. Apr 2010;94(4):444-51. [Medline].
[Best Evidence] Boyer LV, Theodorou AA, Berg RA, et al. Antivenom for critically ill children with neurotoxicity from scorpion stings. N Engl J Med. May 14 2009;360(20):2090-8. [Medline]. [Full Text].
Natu VS, Kamerkar SB, Geeta K, Vidya K, Natu V, Sane S, et al. Efficacy of anti-scorpion venom serum over prazosin in the management of severe scorpion envenomation. J Postgrad Med. Oct-Dec 2010;56(4):275-80. [Medline].
Bawaskar HS, Bawaskar PH. Efficacy and safety of scorpion antivenom plus prazosin compared with prazosin alone for venomous scorpion (Mesobuthus tamulus) sting: randomised open label clinical trial. BMJ. Jan 5 2011;342:c7136. [Medline]. [Full Text].
Gupta BD, Parakh M, Purohit A. Management of scorpion sting: prazosin or dobutamine. J Trop Pediatr. Apr 2010;56(2):115-8. [Medline].
Patil SN. A retrospective analysis of a rural set up experience with special reference to dobutamine in prazosin-resistant scorpion sting cases. J Assoc Physicians India. Apr 2009;57:301-4. [Medline].
Centruroides (Scorpion) Immune F(ab')2 (Equine). Prescribing information. Accessed August 9, 2011. [Full Text].
Bouaziz M, Bahloul M, Kallel H, Samet M, Ksibi H, Dammak H, et al. Epidemiological, clinical characteristics and outcome of severe scorpion envenomation in South Tunisia: multivariate analysis of 951 cases. Toxicon. Dec 15 2008;52(8):918-26. [Medline].
Guerra CM, Carvalho LF, Colosimo EA, Freire HB. Analysis of variables related to fatal outcomes of scorpion envenomation in children and adolescents in the state of Minas Gerais, Brazil, from 2001 to 2005. J Pediatr (Rio J). Nov-Dec 2008;84(6):509-15. [Medline].
Abroug F, Ayari M, Nouira S, et al. Assessment of left ventricular function in severe scorpion envenomation: combined hemodynamic and echo-Doppler study. Intensive Care Med. Aug 1995;21(8):629-35. [Medline].
Amaral CF, Dias MB, Campolina D, Proietti FA, de Rezende NA. Children with adrenergic manifestations of envenomation after Tityus serrulatus scorpion sting are protected from early anaphylactic antivenom reactions. Toxicon. Feb 1994;32(2):211-5. [Medline].
Amaral CF, Lopes JA, Magalhaes RA, de Rezende NA. Electrocardiographic, enzymatic and echocardiographic evidence of myocardial damage after Tityus serrulatus scorpion poisoning. Am J Cardiol. Mar 15 1991;67(7):655-7. [Medline].
Amaral CF, Rezende NA. Treatment of scorpion envenoming should include both a potent specific antivenom and support of vital functions. Toxicon. Aug 2000;38(8):1005-7. [Medline].
Amitai Y, Mines Y, Aker M, Goitein K. Scorpion sting in children. A review of 51 cases. Clin Pediatr (Phila). Mar 1985;24(3):136-40. [Medline].
Bahloul M, Ben Hamida C, Chtourou K, et al. Evidence of myocardial ischaemia in severe scorpion envenomation. Myocardial perfusion scintigraphy study. Intensive Care Med. Mar 2004;30(3):461-7. [Medline].
Bawaskar HS, Bawaskar PH. Clinical profile of severe scorpion envenomation in children at rural setting. Indian Pediatr. Nov 2003;40(11):1072-5. [Medline].
Bawaskar HS, Bawaskar PH. Severe envenoming by the Indian red scorpion Mesobuthus tamulus: the use of prazosin therapy. QJM. Sep 1996;89(9):701-4. [Medline].
Bergman NJ. Scorpion sting in Zimbabwe. S Afr Med J. Feb 1997;87(2):163-7. [Medline].
Bharani AK, Sepaha GC. Myelopathy after scorpion sting. Arch Neurol. Nov 1984;41(11):1130. [Medline].
Biswal N, Mathai B, Bhatia BD. Scorpion sting envenomation: complications and management. Indian Pediatr. Aug 1993;30(8):1055-9. [Medline].
Bond GR. Antivenin administration for Centruroides scorpion sting: risks and benefits. Ann Emerg Med. Jul 1992;21(7):788-91. [Medline].
Brand A, Keren A, Kerem E, Reifen RM, Branski D. Myocardial damage after a scorpion sting: long-term echocardiographic follow-up. Pediatr Cardiol. 1988;9(1):59-61. [Medline].
Carbonaro PA, Janniger CK, Schwartz RA. Scorpion sting reactions. Cutis. Mar 1996;57(3):139-41. [Medline].
Cupo P, Jurca M, Azeedo-Marques MM, Oliveira JS, Hering SE. Severe scorpion envenomation in Brazil. Clinical, laboratory and anatomopathological aspects. Rev Inst Med Trop Sao Paulo. Jan-Feb 1994;36(1):67-76. [Medline].
Curry SC, Vance MV, Ryan PJ, Kunkel DB, Northey WT. Envenomation by the scorpion Centruroides sculpturatus. J Toxicol Clin Toxicol. 1983-1984;21(4-5):417-49. [Medline].
Das S, Nalini P, Ananthakrishnan S, Sethuraman KR, Balachander J, Srinivasan S. Cardiac involvement and scorpion envenomation in children. J Trop Pediatr. Dec 1995;41(6):338-40. [Medline].
De Rezende NA, Dias MB, Campolina D, Chavez-Olortegui C, Diniz CR, Amaral CF. Efficacy of antivenom therapy for neutralizing circulating venom antigens in patients stung by Tityus serrulatus scorpions. Am J Trop Med Hyg. Mar 1995;52(3):277-80. [Medline].
Devi CS, Reddy CN, Devi SL, et al. Defibrination syndrome due to scorpion venom poisoning. Br Med J. Feb 7 1970;1(5692):345-7. [Medline].
el-Amin EO. Issues in management of scorpion sting in children. Toxicon. Jan 1992;30(1):111-5. [Medline].
Freire-Maia L, Campos JA, Amaral CF. Approaches to the treatment of scorpion envenoming. Toxicon. Sep 1994;32(9):1009-14. [Medline].
Gateau T, Bloom M, Clark R. Response to specific Centruroides sculpturatus antivenom in 151 cases of scorpion stings. J Toxicol Clin Toxicol. 1994;32(2):165-71. [Medline].
Ghalim N, El-Hafny B, Sebti F, et al. Scorpion envenomation and serotherapy in Morocco. Am J Trop Med Hyg. Feb 2000;62(2):277-83. [Medline].
Gibly R, Williams M, Walter FG, McNally J, Conroy C, Berg RA. Continuous intravenous midazolam infusion for Centruroides exilicauda scorpion envenomation. Ann Emerg Med. Nov 1999;34(5):620-5. [Medline].
Goyffon M, Vachon M, Broglio N. Epidemiological and clinical characteristics of the scorpion envenomation in Tunisia. Toxicon. 1982;20(1):337-44. [Medline].
Gueron M, Ilia R, Sofer S. The cardiovascular system after scorpion envenomation. A review. J Toxicol Clin Toxicol. 1992;30(2):245-58. [Medline].
Gueron M, Margulis G, Ilia R, Sofer S. The management of scorpion envenomation 1993. Toxicon. Sep 1993;31(9):1071-83. [Medline].
Gueron M, Weizmann S. Catecholamine excretion in scorpion sting. Isr J Med Sci. Jul-Aug 1969;5(4):855-7. [Medline].
Ismail M. The scorpion envenoming syndrome. Toxicon. Jul 1995;33(7):825-58. [Medline].
Karnad DR. Haemodynamic patterns in patients with scorpion envenomation. Heart. May 1998;79(5):485-9. [Medline].
Kric-Dautovic S, Begovic B. Acute renal insuffiency & toxic hepatitis folowing scorpion sting. Med arh. Feb 2007;61:123-4.
Krifi MN, Kharrat H, Zghal K, et al. Development of an ELISA for the detection of scorpion venoms in sera of humans envenomed by Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot): correlation with clinical severity of envenoming in Tunisia. Toxicon. Jun 1998;36(6):887-900. [Medline].
Magalhaes MM, Pereira ME, Amaral CF, et al. Serum levels of cytokines in patients envenomed by Tityus serrulatus scorpion sting. Toxicon. Aug 1999;37(8):1155-64. [Medline].
Malhotra KK, Mirdehghan CM, Tandon HD. Acute renal failure following scorpion sting. Am J Trop Med Hyg. May 1978;27(3):623-6. [Medline].
Muller GJ. Scorpionism in South Africa. A report of 42 serious scorpion envenomations. S Afr Med J. Jun 1993;83(6):405-11. [Medline].
Murthy KR, Hase NK. Scorpion envenoming and the role of insulin. Toxicon. Sep 1994;32(9):1041-4. [Medline].
Naqvi R, Naqvi A, Akhtar F, Rizvi A. Acute renal failure developing after a scorpion sting. Br J Urol. Aug 1998;82(2):295. [Medline].
Nouira S, Boukef R, Nciri N, et al. A clinical score predicting the need for hospitalization in scorpion envenomation. Am J Emerg Med. May 2007;25(4):414-9. [Medline].
Otero R, Navio E, Cespedes FA, et al. Scorpion envenoming in two regions of Colombia: clinical, epidemiological and therapeutic aspects. Trans R Soc Trop Med Hyg. Dec 2004;98(12):742-50. [Medline].
Radmanesh M. Androctonus crassicauda sting and its clinical study in Iran. J Trop Med Hyg. Oct 1990;93(5):323-6. [Medline].
Radmanesh M. Cutaneous manifestations of the Hemiscorpius lepturus sting: a clinical study. Int J Dermatol. Jul 1998;37(7):500-7. [Medline].
Rajarajeswari G, Sivaprakasam S, Viswanathan J. Morbidity and mortality pattern in scorpion stings. (A review of 68 cases). J Indian Med Assoc. Oct 1979;73(7-8):123-6. [Medline].
Reddy CR, Suvarnakumari G, Devi CS, Reddy CN. Pathology of scorpion venom poisoning. J Trop Med Hyg. May 1972;75(5):98-100. [Medline].
Sofer S. Scorpion envenomation. Intensive Care Med. Aug 1995;21(8):626-8. [Medline].
Sundararaman T, Olithselvan M, Sethuraman KR, Narayan KA. Scorpion envenomation as a risk factor for development of dilated cardiomyopathy. J Assoc Physicians India. Nov 1999;47(11):1047-50. [Medline].
Tu A, ed. Handbook of Natural Toxins: Invertebrate Venoms. Vol 2. New York, NY: Marcel Dekker; 1984:513-678.
Velasco-Castrejon O, Lara-Aguilera R, Alatorre H. [Clinical and epidemiological aspects of scorpion sting in a hyperendemic area]. Rev Invest Salud Publica. Apr-Jun 1976;36(2):93-103. [Medline].

